Skip to content
V-Biognostics
Toggle menu
  • About
  • Contact
  • Products
    • Osteocalcin (1-49) Human (Synthetic)
    • Antibiotics
      • Amphotericin B (Fungizone)
      • Bestatin (Ubenimex)
      • Bleomycin Sulfate
      • Brefeldin A
      • Daptomycin
      • G418, Sulfate
      • Mitomycin C
      • Thiostrepton
      • Valinomycin
    • Protease Inhibitors 1
      • AEBSF
      • Alafosfalin (Synthetic)
      • ALLN (Calpain Inh. I)
      • ALLM (Calpain Inh. II)
      • Amastatin, HCl
      • Antipain, 2HCl
      • Bestatin, HCl
      • Calpain Inh. III
      • Calpeptin
    • Protease Inhibitors 2
      • E-64 (Synthetic)
      • E-64d
      • Elastase Inh. I
      • Leupeptin, HCl
      • Leupeptin, Hemisulfate
      • MG-132
      • Pepstatin A
      • Phosphoramidon
      • RG108
      • TLCK, HCl
  • GERBU
    • GERBU Esterquat Product List
    • GERBU Adjuvant Product List
    • GERBU Adjuvant Introduction
    • GERBU Adjuvants Product Manuals
  • Articles

Author: Paul

April 25, 2022News

From the floor at AACR 2022: a video roundup

BioTechniques News Tristan Free At this year’s meeting of the American Association for Cancer Research (8th-13th April; New Orleans, LA, USA) we […]

April 25, 2022News

Is The Earth BioGenome Project a success story for whole-genome sequencing? Find out in your latest issue of BioTechniques

BioTechniques News Aisha Al-Janabi In this issue of BioTechniques, we present an artificial intelligence-powered time-lapse imaging microscopy method for studying T cells, […]

April 25, 2022News

I spy with my little eye developments towards a color-sensing ‘electric eye’

BioTechniques News Aisha Al-Janabi A team of researchers has made progress towards developing an ‘electric eye’ with improved color recognition, using a […]

April 22, 2022News

New study identifies subset of T cells that regulate the immune system

BioTechniques News Georgia Bickerton Researchers find that blocking the checkpoint protein PD-L1 unexpectedly activates regulatory T cells (effector Tregs), reducing the ability […]

April 21, 2022News

The five diseases behind language impairment

BioTechniques News Aisha Al-Janabi An extensive autopsy study identifies diseases that cause progressive impairments of language, such as difficulty with grammar or […]

April 20, 2022News

Understanding disparities in Alzheimer’s disease: an interview with Renã Robinson

BioTechniques News Tristan Free US statistics indicate that older African Americans and Hispanics are 2–3 times more likely to develop Alzheimer’s disease […]

April 19, 2022News

Does being more social make your brain bigger?

BioTechniques News Georgia Bickerton New findings from a project studying the behavior of rhesus macaques have found an interesting link between macaque […]

April 14, 2022News

Novel drug may prove useful as a treatment for dementia

BioTechniques News Annie Coulson A research team from Sage Therapeutics (MA, USA) have completed a preliminary study utilizing a novel drug – SAGE-718 – […]

April 13, 2022News

It’s time to fight back: honey bees vs. Verroa mites

BioTechniques News Georgia Bickerton A new breed of honey bees, named “Pol-line”, has been selectively bred to identify and remove the Varroa […]

April 13, 2022News

Genome analysis shows clownfish aren’t like other anemonefish

BioTechniques News Aisha Al-Janabi There’s no more clowning around, as the genome of the false clownfish has been reported at the chromosome-scale, […]

April 12, 2022News

AACR22: A COVID-19 vaccine for people with B cell deficiency

BioTechniques News Georgia Bickerton Those with B cell deficiencies are still vulnerable following current COVID-19 vaccinations; however, researchers have created a new […]

April 11, 2022News

Peering through the eyes of the Proteus

BioTechniques News Georgia Bickerton Researchers have produced x-ray-computed microtomography scans of the endangered Proteus anguinus – an aquatic salamander – allowing scientists […]

April 11, 2022News

AACR22: Building a ‘family tree’ of breast tumors may improve treatment options

BioTechniques News Georgia Bickerton Recurrent non-invasive breast tumors may not always be related to the primary lesion and determining this could improve […]

April 8, 2022News

Artificial intelligence predicts side effects of combination therapies

BioTechniques News Aisha Al-Janabi A machine learning model shows promise in predicting potential adverse effects from new drug combination therapies, a method […]

April 7, 2022News

How can we predict bone loss in premenopausal women?

BioTechniques News Aisha Al-Janabi Researchers discover that measuring the level of anti-Mullerian hormone in premenopausal women could predict bone loss, and lead […]

April 6, 2022News

Researchers use CRISPR gene editing to uncover potential HIV treatments

BioTechniques News Georgia Bickerton Using CRISPR researchers have identified 86 genes that could be associated with HIV replication and disease, opening doors […]

April 6, 2022News

Tuberculosis may be connected with premature cellular aging

BioTechniques News Aisha Al-Janabi A study by researchers at Baylor College of Medicine (TX, USA), discovered that tuberculosis survivors’ cells had prematurely […]

April 1, 2022News

Biodegradable brain implants (dis)solve the need for risky implant removal surgery

BioTechniques News Aisha Al-Janabi A novel biodegradable brain implant can harmlessly dissolve into the body after monitoring the brain chemistry of mice, […]

March 31, 2022News

Extracellular vesicles found to drive extracellular communications

BioTechniques News Aisha Al-Janabi Tiny nano-sized bubbles called extracellular vesicles could answer the unsolved mystery of how cells communicate with each other.   […]

March 31, 2022News

Can SARS-CoV-2 variants cause different long COVID symptoms?

BioTechniques News Georgia Bickerton An observational study of long COVID patients in Italy revealed that different neurological and emotional symptoms were reported […]

Posts navigation

< 1 … 25 26 27 … 42 >
Partnering with:   Quartett GERBU Adjuvants

V-BIOGNOSTICS, "Ingredients For Life" is a BioTech company devoted to research in life science reagents worldwide. We source difficult to find biochemicals for the advancement in research of antibody production, Immunohistochemistry, drug development, molecular biology, cell biology, cancer research, Immunotherapy, Oncology, drug discovery, and agricultural biotechnology. We work hard for speedy processing and delivery of your products and at very competitive pricing offering you a high quality alternative to big pharma for your sourcing and manufacturing needs.

D&B VERIFIED Seal

We Supply the highest quality protease inhibitors, antibiotics, and Adjuvants including: Bestatin HCl, Leupeptin Hemisulfate / Hydrochloride, AEBSF, G418, Elastatinal, E-64, Pepstatin, Calpain, Bleomycin Sulfate, Proteinase K, MG-132, ALLM, ALLN, Antipain, Anti-Human Rabbit IgG, GERBU Monoclonal/Polyclonal Adjuvant, synthetic and custom synthesis. Please Contact Us or visit our Products, About, or Terms pages for more information.

Biotech Articles

  • AI unexpectedly uncovers potential antibiotics in prion proteins
  • Macrophage vs melanoma: immune cells attack live cancer cells in world-first footage
  • The biotech bi-weekly: multiomics, human cell-based research, next-gen cell recovery and biomarker development
  • Double bubble: micro- and nanobubbles boost microplastic removal from wastewater
  • Clicking into place: antibody–drug conjugates target difficult-to-treat tumors
  • A smartwatch for plants? Scientists create ‘wearable’ sensors for tracking plant health
© 2026 V-Biognostics. Proudly powered by Sydney